Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Inside IC System’s Successful Partnership with Genomind

Bryan Campbell, Business Development Manager with IC System, and Tom Hess, Senior Vice President and Chief Financial Officer of Genomind, join Tyler Kern to discuss the companies’ successful working relationship forged during the COVID-19 pandemic.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Finding a perfect match can be difficult, but sometimes things just click. That’s the case with IC System and Genomind.

Genomind, a company utilizing genetics as a data point in diagnosing mental health challenges, wanted a recovery agency that, instead of aggressively going after those who hadn’t yet paid for the services provided, would take a tactful approach.

“We didn’t set any goals other than we didn’t want patients to be upset and didn’t want them to call the doctors and upset the doctors, which would cascade into them calling our sales reps,” said Thomas Hess, Senior Vice President and Chief Financial Officer of Genomind. “We had zero expectations for collections. Our goal was just not to upset people.”

Genomind had chatted with other companies in the same space as IC System and ran a pilot with IC once Hess found the IC System website and was impressed with the transparency, family-oriented nature of the business and site design.

Rather than simply not upsetting people, Genomind found a success rate that far outpaced their goals, leading to millions of dollars added in revenue and recovery.

Genomind was an ideal client for IC System, said Bryan Campbell, Business Development Manager, since IC System is always happy to modify its approach and work with each client on an individual basis.

The partnership looked a bit different during the pandemic, but the companies were able to come together using virtual meeting platforms to make sure everyone was reaching their goals.

“Everybody’s doing the same thing, but we at IC System, from a sales standpoint, say that everybody is operating at the same way. You’ve got to do it better,” he said. “You have to build those relationships and make sure those carry through in a new way and stronger way.

“We just got after that. They were real treats to able to get on, to use the new technology and depend on it rather than just being on the phone. It’s like we haven’t missed a beat.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

A Nature study reveals a significant increase in FDA-authorized digital medical devices over the past two decades. However, the FDA's regulatory databases are still unable to specify which of these devices contain software. This gap points to the need for improved database capabilities to better track digital medical devices.

  • 01FDA-authorized digital medical devices have increased significantly over the last 20 years.
  • 02The current FDA regulatory databases lack the capability to identify devices that include software.

Aug 5, 2026

Leading with Purpose: Dr. David Foster on Faith, Healthcare Leadership, and Physician Collaboration

Dr. David Foster discusses the importance of faith in healthcare leadership and the role of physician collaboration. The conversation emphasizes how values-driven leadership can positively impact patient care. The dialogue also explores the significance of integrating personal beliefs in professional settings.

  • 01Values-driven leadership can significantly enhance patient care.
  • 02Integrating personal beliefs in professional settings can benefit healthcare leadership.
  • 03Collaboration among physicians is crucial for effective healthcare leadership.

Aug 4, 2026

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512